| Members |
targetComponentId |
| Epirubicin hydrochloride 200mg/100mL solution |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| epirubicinhydroklorid 2 mg/ml, infusionsvätska, lösning, flaska 100 ml |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Epirubicin hydrochloride 2mg/mL injection solution 100mL vial |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| episiotomisår |
Episiotomy wound |
| epitelial tumör på äggstock, FIGO-stadium I |
I |
| epitelial tumör på äggstock, FIGO-stadium IA |
IA |
| epitelial tumör på äggstock, FIGO-stadium IB |
IB |
| epitelial tumör på äggstock, FIGO-stadium IC |
IC |
| epitelial tumör på äggstock, FIGO-stadium IIA |
American Joint Committee on Cancer stage IIA (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium IIB |
American Joint Committee on Cancer stage IIB (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium III |
American Joint Committee on Cancer stage III (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium IIIA |
American Joint Committee on Cancer stage IIIA (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium IIIB |
American Joint Committee on Cancer stage IIIB (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium IIIC |
American Joint Committee on Cancer stage IIIC (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium IV |
IV |
| epitelial tumör på äggstock, FIGO-stadium IVA |
American Joint Committee on Cancer stage IVA (qualifier value) |
| epitelial tumör på äggstock, FIGO-stadium IVB |
IVB |
| Epithelial stromal corneal dystrophy |
Epithelial basement membrane dystrophy (disorder) |
| benign epitelial tumör |
Benign epithelial neoplasm |
| epitelioidalt hemangioendoteliom |
Epithelioid hemangioendothelioma, malignant (morphologic abnormality) |
| Epoetin alfa 10000unt/mL injection |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa, 10 000 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Epoetin alfa 10000unt/mL solution |
Product containing precisely epoetin alfa 10000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa, 20 000 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Epoetin alfa 20000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL injection |
Epoetin alfa 2000 unit/mL solution for injection |
| epoetin alfa, 2 000 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Epoetin alfa 2000 unit/mL solution for injection |
| Epoetin alfa 2000unt/mL solution |
Epoetin alfa 2000 unit/mL solution for injection |
| epoetin alfa, 3 000 enheter/ml, injektionsvätska, lösning, flaska 1 ml |
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug) |
| epoetin alfa, 4 000 IE/ml, injektionsvätska, lösning, flaska 1 ml |
Epoetin alfa 4000 unit/mL solution for injection |
| Epoetin alfa 4000unt/mL solution |
Epoetin alfa 4000 unit/mL solution for injection |
| epoetin beta 10 000 IE, pulver och vätska till injektionsvätska, lösning, cylinderampull, kassett |
Epoetin beta only product in parenteral dose form |
| epoetin beta 10 000 IE, pulver till injektionsvätska, lösning, cylinderampull |
Epoetin beta only product in parenteral dose form |
| epoetin beta 100 000 IE, pulver och vätska till injektionslösning, flaska |
Epoetin beta only product in parenteral dose form |
| epoetin beta 100 000 IE, pulver till injektionsvätska, lösning, flaska |
Epoetin beta only product in parenteral dose form |
| epoetin beta 20 000 IE, pulver och vätska till injektionsvätska, lösning, cylinderampull, kassett |
Epoetin beta only product in parenteral dose form |
| epoetin beta 20 000 IE, pulver till injektionsvätska, lösning, cylinderampull |
Epoetin beta only product in parenteral dose form |
| epoetin beta 50 000 IE, pulver och vätska till injektionslösning, flaska |
Epoetin beta only product in parenteral dose form |
| epoetin beta 50 000 IE, pulver till injektionsvätska, lösning, flaska |
Epoetin beta only product in parenteral dose form |
| epoetin beta 500 IE, pulver och vätska till injektionslösning, flaska |
Epoetin beta only product in parenteral dose form |
| epoetin beta 60 000 IE, pulver och vätska till injektionsvätska, lösning, cylinderampull, kassett |
Epoetin beta only product in parenteral dose form |
| epoetin beta 60 000 IE, pulver till injektionsvätska, lösning, cylinderampull |
Epoetin beta only product in parenteral dose form |
| Epoophoron |
Wolffian body rest |
| Epsteins syndrom |
MYH9 related disease |
| Eptifibatide 0.75mg injection |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 0.75mg/mL injection |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Eptifibatide 0.75mg/mL injection solution 100mL bag |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| eptifibatid 750 mikrogram/ml, infusionssvätska, lösning, flaska 100 ml |
Product containing precisely eptifibatide 750 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| ekvint anti-humant tymocytimmunglobulin 20 mg/ml, injektionsvätska, lösning, flaska 5 ml |
Product containing precisely equine antithymocyte immunoglobulin 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| antikropp mot arteritvirus hos hästdjur |
Anti viral antibody |
| antikropp mot infektiöst hästanemivirus |
Anti viral antibody |
| Equus asinus asinus |
Equus asinus |
| ergonovinmaleat 200 mikrogram/ml, injektionsvätska, lösning, ampull |
Ergometrine 200 microgram/mL solution for injection |
| Ergot compound allergy |
Allergy to ergot alkaloid (finding) |
| eribulinmesylat 0,5 mg/ml, injektionsvätska, lösning |
Product containing only eribulin in parenteral dose form (medicinal product form) |
| eribulinmesylat 0,5 mg/ml, vätska för intravenös infusion, lösning |
Product containing only eribulin in parenteral dose form (medicinal product form) |
| felaktigt begrepp |
Erroneous component (foundation metadata concept) |
| ertapenem 1 g, pulver till infusionsvätska, lösning, flaska |
Ertapenem (as ertapenem sodium) 1 g powder for solution for injection vial |
| Erwinia ananas |
Pantoea ananatis (organism) |
| Erwinia cacticida |
Pectobacterium cacticida (organism) |
| Erwinia cancerogena |
Enterobacter cancerogenus |
| Erwinia carnegieana |
Genus Dickeya (organism) |
| Erwinia carotovora |
Pectobacterium carotovorum (organism) |
| Erwinia carotovora ss. atroseptica |
Pectobacterium atrosepticum (organism) |
| Erwinia carotovora ss. betavasculorum |
Pectobacterium betavasculorum (organism) |
| Erwinia carotovora ss. carotovora |
Pectobacterium carotovorum subspecies carotovorum (organism) |
| Erwinia carotovora subsp odorifera |
Pectobacterium carotovorum subspecies odoriferum (organism) |
| Erwinia cartovora subsp cartobora |
Pectobacterium carotovorum subspecies carotovorum (organism) |
| Erwinia cartovora subsp wasabiae |
Pectobacterium wasabiae (organism) |
| Erwinia chrysanthemi |
Dickeya chrysanthemi (organism) |
| Erwinia cypripedii |
Pantoea cypripedii (organism) |
| Erwinia herbicola |
Pantoea agglomerans |
| Erwinia nigrifluens |
Brenneria nigrifluens (organism) |
| Erwinia paradisiaca |
Dickeya paradisiaca (organism) |
| Erwinia quercina |
Lonsdalea quercina (organism) |
| Erwinia rhapontici |
Pectobacterium rhapontici (organism) |
| Erwinia rubrifaciens |
Brenneria rubrifaciens (organism) |
| Erwinia salicis |
Brenneria salicis (organism) |
| Erwinia stewartii |
Pantoea stewartii subsp stewartii |
| Erwinia uredovora |
Pantoea ananatis (organism) |
| Erythema infectiosum virus |
Primate erythroparvovirus 1 (organism) |
| erytromycin 250 mg, enterogranulat i kapsel |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| erytromycin 250 mg, enterokapsel |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| erytromycin 250 mg, kapsel med modifierad frisättning |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin ethylsuccinate 100 mg/2.5mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 100mg/2.5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erytromycinetylsuccinat 100 mg/2,5 ml, suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL liquid |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erytromycinetylsuccinat 200 mg/5 ml, suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 400mg film |
Erythromycin (as erythromycin ethyl succinate) 400 mg oral tablet |
| Erythromycin ethylsuccinate 400mg/5 mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 400mg/5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 400mg/5mL powder |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erytromycinetylsuccinat 400 mg/5 ml, suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin lactobionate 1g injection (pdr for recon) |
Product containing only erythromycin in parenteral dose form (medicinal product form) |
| erytromycinlaktobionat 1 g, pulver till infusionsvätska, lösning, flaska |
Product containing only erythromycin in parenteral dose form (medicinal product form) |
| Erythromycin lactobionate 500mg |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg injection (pdr for recon) |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| erytromycinlaktobionat 500 mg, pulver till infusionsvätska, lösning, flaska |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg/mL injection |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
FHIR